Antiviral drugs are medicines that decrease the ability of flu viruses to reproduce. when used as directed, antiviral drugs may help reduce the duration of flu.
This report contains market size and forecasts of Antiviral Drugs in global, including the following market information:
- Global Antiviral Drugs Market Revenue, 2017-2022, 2023-2028, ($ millions)
- Global Antiviral Drugs Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Antiviral Drugs companies in 2021 (%)
The global Antiviral Drugs market was valued at 42060 million in 2021 and is projected to reach US$ 52240 million by 2028, at a CAGR of 3.1% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Reverse Transcriptase Inhibitors Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Antiviral Drugs include Roche, Johnson & Johnson, Merck, Novartis, Bristol-Myers Squibb, Gilead Sciences, GlaxoSmithKline and AbbVie, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Antiviral Drugs manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Antiviral Drugs Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Antiviral Drugs Market Segment Percentages, by Type, 2021 (%)
- Reverse Transcriptase Inhibitors
- Protease Inhibitors
- Fusion Inhibitors
- Immune System Modulators
Global Antiviral Drugs Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Antiviral Drugs Market Segment Percentages, by Application, 2021 (%)
- Hepatitis Therapeutics
- HIV/AIDS Therapeutics
- Herpes Therapeutics
- Influenza Therapeutics
Global Antiviral Drugs Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Antiviral Drugs Market Segment Percentages, By Region and Country, 2021 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
- Key companies Antiviral Drugs revenues in global market, 2017-2022 (Estimated), ($ millions)
- Key companies Antiviral Drugs revenues share in global market, 2021 (%)
- Key companies Antiviral Drugs sales in global market, 2017-2022 (Estimated), (K Units)
- Key companies Antiviral Drugs sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
- Roche
- Johnson & Johnson
- Merck
- Novartis
- Bristol-Myers Squibb
- Gilead Sciences
- GlaxoSmithKline
- AbbVie
